CLINICAL_TRIALS
trial_result
· 2019-04-04
Clinical Trial Update: Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma [Phase 2]
Summary
Phase 2 trial of methoxyamine and temozolomide in recurrent glioblastoma (terminated; results posted).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Adult Brain Glioblastoma | Phase 2 | Status: TERMINATED | Results posted: 2019-04-04